Reuters logo
BRIEF-Breckenridge Pharmaceutical announces final ANDA approval for Bendamustine HCL powder for IV
January 6, 2017 / 7:50 PM / 9 months ago

BRIEF-Breckenridge Pharmaceutical announces final ANDA approval for Bendamustine HCL powder for IV

Jan 6 (Reuters) - Breckenridge Pharmaceutical Inc

* Breckenridge Pharmaceutical Inc Announces final anda approval for bendamustine hcl powder for iv (treanda)

* Breckenridge - intends to launch anda on november 1, 2019, or earlier based on certain circumstances Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below